Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
A federal securities class action lawsuit has been filed against GPGI (formerly CompoSecure) and its executives over alleged misrepresentations in the Husky Technologies acquisition.
Tempest Therapeutics partnered with Senlang Biotechnology to advance TPST-4003, a CD7-targeted in vivo CAR-T, with first patient dosing expected in Q4 2026.
